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CTL are partly responsible for the immune response to influenza viruses in
both mouse and man . The majority of CTL detectable in vivo and early in
polyclonal cultures in vitro, crossreact on target cells infected with all strains of
A viruses but not B viruses (1, 2) . This crossreactive CTL response may play a
role in the heterotypic protection observed in rodents and man after infection
by serologically distinct influenzaA strains (3, 4) .
The identification of the conserved viral molecules that are recognized by
crossreactive CTL has depended on rDNA techniques to express individual viral
proteins in cell lines in vitro . In both mice and man the predominant conserved
epitopes turn out to be on the nonglycosylated proteins of the virus (5-9). The
nucleoprotein (NP)' is a major antigen in H-2k, -d, and -b strains of mice (5, 6)
and in the majority of humans (7). PB 1, PB2, PA, NS I , andM I also have been
shown to be recognized by class I-restricted CTL (7, 8) . The CTL response to
NP appears to be under strict genetic control in both mice and man, responder
status being conferred by single polymorphic class I genes in each case (10-12) .
Recent efforts (10) to map the epitopes recognized to regions of the NP
sequence using deletion mutants of the NP gene have shown that the immuno-
dominant epitopes lie in different regions of the molecule in H-2b and -k strains
of mice . These experiments also showed that the recognition ofNP by CTL was
not dependent on a definable signal sequence in the molecule, and led to the
suggestion that NP may be recognized after degradation in the target cell .
Further work (13) demonstrated that an epitope mapped to a short region of
NP that had undergone genetic change since 1934 could be replaced in vitro
with a short peptide (amino acids 366-379) . Two mutually exclusive epitopes
were thus defined using CTL clones that differentiated between two groups of
A viruses isolated between 1934-1943 and 1946-1968. During the course of
these experiments an additional epitope recognized by HLA-B37-restricted
human CTL was defined with a second NP peptide (335-349) (13) .
This work was supported by the Medical Research Council of Great Britain .
' Abbreviations used in this paper :
￿
HAU, hemagglutinin units ; K/T, killer-to-target ratio ; NP,
influenza virus nucleoprotein .
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In this paper we extend these findings by showing that the two conserved NP
epitopes recognized by CBA (H-2k) and C57BL/10 (H-2b) mice defined in the
deletion analysis (10) can also be replaced with peptides in vitro . We examine
the details of the specificity of two CTL clones from C57BL/10 mice that
recognize different epitopes on the peptide 365-379 through thesame restriction
element (Db), and show that recognition by clone F5 (5, 10, 13) is sensitive to
the single conserved substitution Asp to Glu at position 372 in NP . Finally, we
demonstrate that the complete NP protein is inefficient at sensitizing target cells
for lysis by CTL in comparison to peptide . These results strengthen the hypoth-
esis that a ubiquitous mechanism exists by which newly synthesized viral (and
possibly host) proteins are degraded and presented to CTL in association with
class I molecules of the MHC .
Materials and Methods
Mice .
￿
3-6-mo-old C57BL/10 female mice used as responding cell donors were ob-
tained from National Institute of Medical Research, London, United Kingdom .
In Vivo Priming ofMice.
￿
Mice were anesthetized with ether and primed by intranasal
infection with 5 hemagglutinin units (HAU) of E61-13-H17 virus or by intravenous
inoculation with 100 HAU ofA/PR/8/34 virus as infectious allantoic fluid diluted in 50
tcl PBS as described (14) .
Influenza Virus Strains .
￿
The recombinant A viruses X31 (15) and E61-13-H17 (ref-
erence 16 where this virus is referred to as recombinant 33) differ only in the origin of
their genes for nucleoprotein . E61-13-H 17 contains the 1968 NP gene from A/HK/8/68,
and X31 contains the 1934 NP gene from A/PR/8/34 . Virus was grown in the allantoic
sacs of 11-d-old embryonated chicken eggs and stored as infectious allantoic fluid at
-70°C .
Peptide Synthesis .
￿
Peptides were synthesized by solid-phase techniques on a peptide
synthesizer (No . 430A Applied Biosystems, Inc ., Foster City, CA) as described (13) . The
purity of the crude product was determined by HPLC on a C-18 reverse-phase column .
All the peptides described here contained >90% of the desired product .
Transfected L Cells. L cells were cotransfected with the Db class I gene and the
BAM577/793 deletion mutant of the NP cDNA (under the transcriptional control of the
Herpes Simplex virus thymidine kinase promoter) exactly as described previously (10) .
The BAM577/793 mutant expresses amino acids 1-87, 160-498 ofNP and its construc-
tion has been described previously (17) . The L cell transfectants expressing the full length
NP (amino acids 1-498), and the deletion mutants PVU705 (amino acids 1-130),
PVU1295 (amino acids 1-327), and IMP1295 (amino acids 1, 2, 328-498) have been
described (10) .
Peptide-pulsed Target Cells. L cells transfected with the gene for Db (L/Db) were
labeled with 5 'Cr as described (14), then resuspended in RPMI 1640 medium containing
10% FCS and peptide at 30 AM/liter for 1 h . They were then washed four times as
described (13) before use in the cytotoxicity assay .
Purification of Influenza Nucleoprotein Produced in Escherichia coli .
￿
The NP was ex-
pressed in E . coli as a fusion protein with the X Cro gene product (18) . The final NP
product contains an NH2-terminal extension of 32 heterologous amino acids, which do
not interfere with its biological activities (19) . It was purified by immune-affinity chro-
matography as described (19), or by ion exchange chromatography as follows .
Briefly, induced bacterial cultures were pelleted, resuspended in 10 mM Tris, HCI, pH
7 .0, 1 mM PMSF (Sigma Chemical Co ., St . Louis, MO) and were lysed by sonication . The
extract was clarified by centrifugation and applied to a column of DEAE-Sepharose (Bio-
Rad Laboratories, Richmond, CA) . NP was eluted from the column using a linear gradient
of 0-0.5 M NaCI, and fractions containing NP (detected by gel electrophoresis) were
pooled, and made up to 50 mM Tris-acetate, pH 5.5 . A precipitate that formed at 0 °C1510
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was removed by centrifugation and the supernatant was dialyzed against 10mM Tris, pH
7.0/1 mM PMSF . The extract was applied to a column of P11-phosphocellulose (Whatman
Inc ., Clifton, NJ) and NP was eluted with a linear gradient of 0-1 M NaCl. NP prepared
in this way was judged to be >90% pure by gel electrophoresis and was stored for use in
0.5 M NaCl at -20°C . The concentration of the purified product (Mr 60,000) was
measured by Bradford's method (20) . For some experiments, the purified recombinant
NP was denatured with 7 M guanidine-HCI followed by reduction and alkylation as
described by Campbell et al . (21) before testing in the cytotoxicity assay .
Polyclonal Cytotoxic T Cell Cultures .
￿
The methods used to initiate and maintain cultures
of influenza specific CTL have been described (14) .
Polyclonal CBA (H-2k) CTL.
￿
Male CBA mice were primed by intravenous injection of
100 HAU ofA/PR/8/34 virus . 2 wk later they were killed and cultures of their spleen
cells were initiated in vitro by stimulation with A/PR/8/34 virus as described (14), except
that the supernatant from PMA-stimulated EL4 cells (22) (EL4 supernatant) was used as
a source ofT cell growth factors after 1 wk in vitro . After three weekly stimulations with
A/PR/8/34 virus-infected feeder cells the culture was tested in the cytotoxicity assay .
CTL Clone 11 .
￿
Clone 11 was derived from a C57BL/10 mouse primed intranasally
with E61-13-H17 (1968 NP) . Established polyclonal CTL lines were raised, as described
previously (14), and maintained on X31 (which expresses the 1934 NP)-infected feeder
cells . The CTL were cloned by limiting dilution, as described (23), using as a source of
growth factors the supernatant from PMA-stimulated EL4 cells (22) diluted to 5-10%
vol/vol . Once the specificities of the clones were known, the cultures were maintained on
peptide-pulsed, irradiated (2,000 rad) spleen cells . Irradiated spleen cells were pulsed with
100,ug/ml of appropriate peptide diluted in RPMI/10% FCS for 1 h at 37°C, then they
were washed three times in PBS and used as feeder cells as described previously (13) .
CTL Clone F5 .
￿
F5 is a Db-restricted C57BL/6 CTL clone specific for 1968 NP and
has been described previously (5, 10, 13) .
"Chromium-release Assay .
￿
A standard procedure was used (24) for target cells either
infected with influenza virus, transfected with NP gene fragments, or pulsed with peptide
and washed before use in the assay (13), (Figs . 1-3). "Cr release was calculated as follows :
specific release = [(release by CTL - medium release)/(2 .5% Triton release - medium
release)] X 100 .
Each experimental point was measured in duplicate against quadruplicate controls in
medium alone . Spontaneous "Cr release by target cells in medium in the absence ofCTL
was<18% of that released by Triton X-100 .
Dose Response Titrations ofPeptides.
￿
For all of the dose-response experiments (Figs . 3-
6), L cells transfected with the class I gene Db were used (5) as target cells . Peptides in
RPMI 10 or NP in isotonic saline solution were dispensed in round-bottomed 96-well
Sterilin microtiter plates, as described (13), in 0.05 ml, and a series of dilutions were made
over a range optimized in previous experiments . "Cr-labeled LDb cells (10') in 0.05 ml
were added to each well followed by a fixed number of CTL in 0.1 ml (to give the
CTL/target cell ratios described in the legends to the figures) . The 6-h assay was then
performed as previously described (13, 14) . The results in Figs . 3-6 were calculated in
the following way to normalize the titrations to the 0% line : [(Release in the presence of
CTL and peptide - release byCTL alone)/(2.5% Triton release - release by CTL alone)]
X 100 .
The release of"Cr from target cells in the presence ofCTL (at the K/T ratios shown
in Figs . 3-6) but no peptide was between 16-36% ofthe counts released by Triton . These
values were slightly greater than the spontaneous release of "Cr from target cells in the
absence of peptide or CTL (14-29%) . Within the dose ranges shown none of the peptides
alone had any detectable effect on the spontaneous release of"Cr from target cells .
Results
The Major Conserved Epitope ofNP Recognized by CBA (H-2k) CTL Is Defined by
Peptide 50-63 .
￿
We have previously shown (10) that a major proportion of CBAw m
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FIGURE 1 . Recognition by pol-
yclonal CBA CTL line of L/Db
target cells transfected with full
length or truncated NP genes (a-
d) andL/Db cells pulsed with pep-
tides (e andf) . The CTL line was
derived from a CBA mouse as
described in Materialsand Meth-
ods . After 2 wk of stimulation in
vitro with A/PR/8/34 virus, the
CTL line was split, and one-half
was stimulated with feeder cells
pulsed with 30 uM/liter of pep-
tide 50-63, and the other half
with A/PR/8/34 virus . (0) CTL
stimulated three times with
A/PR/8/34 virus and tested on
transfected or peptide-treated
L/D6 target cells; (0) the same
effector cells on untreated L/Db
target cells ; (/) CTL stimulated
twice with A/PR/8/34 virus, and
once with spleen cells pulsed with
peptide 50-63, (0) thesame CTL
tested on untreated L/Db target
cells .
andC3H (H-2k) CTL generated in secondary in vitro responses to influenza are
specific for a conserved epitope of NP localized to the NH2-terminal region of
the molecule comprising amino acids 1-130 . Fig . 1 shows an extension of this
analysis using a further transfected target cell expressing a deletion mutant of
NP (BAM 577/793 ; see reference 17) which localized the predominant epitope
to the NH2-terminal 87 amino acids of NP .
Recently, the observation has been made (25) that epitopes recognized by T
cells that can be defined with synthetic peptides in vitro tend to contain amino
acids with defined physical properties in the following order more often than
would be expected by chance : (Charged or Glycine) - (Hydrophobic) - (Hydro-
phobic) - (Charged or Polar) .
The NH2-terminal 87 amino acids of NP contain three such regions ("motifs")
of sequence . The first peptide synthesized to contain one of these was composed
ofamino acids 50-63 (Table 1), which contains the commonly observed motifin
the sequence Arg-Leu-Ile-Gln (see reference 26 for the NP sequence from
A/NT/60/68) . The currently updated predictive program described by De Lisi
a b c
NP 1-498 PVII 705 BAM 577/793
1-130 1-87,160-498
d e f
IMP 1295 PEPTIDE PEPTIDE
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TABLE I
Summaryofthe NP Peptides Recognized by Class I-restricted CTL
For the sequences of the nucleoproteins from 1968 and 1934 see references 26 and 28 .
and Berzofsky (27) selects 65 of the 87 NH 2-terminal residues, which include the
sequence 50-63.
CTL recognition of this peptide was readily detected in polyclonal cultures
with NP-specific activity from CBA (H-2k) mice (Fig . 1) . CBA cultures did not
recognize the peptide 365-379, which was recognized efficiently by C57BL (H-
2b) CTL (described below) . CTL with specificity for peptide 50-63 could be
rapidly enriched in polyclonal cultures by restimulation with peptide-pulsed
feeder cells and a source of T cell growth factors as described (22) (Fig . 1 e) . The
MHC restriction for this peptide can be inferred, from the studies of Pala and
Askonas, to be through Kk (11) ; they have shown that all NP-specific CTL in
CBA mice are restricted through the class I molecule Kk .
The Major Conserved Epitope on NP Recognized by C57BL (H-2b) Mice Defined
with Peptide 365-379 . Within the polyclonal CTL response to influenza in
C57BL there exists a predominant population that recognize target cells express-
ing NP in isolation afterDNA transfection (5) . The majority of theseNP specific
CTL are crossreactive for all A strains of influenza that have been associated
with epidemics in man (5, 10). There also exists a minor population of H-2b
CTL that recognize a genetically variable region of NP that can be defined with
subgroups of influenza A isolates (5, 14) . Recently (13), CTL clones specific for
the latter determinant were shown to recognize a synthetic peptide representing
the amino acids 365-379 of NP . Two noncrossreacting epitopes were demon-
strated, one expressed in viruses isolated between 1934 and 1943, the other
differing by two amino acidsand expressed in viruses isolated between 1946 and
1968 (13, 14) . These results are summarized in Table 1 .
The majority of the NP-specific CTL detected in polyclonal cultures from H-
2b mice, which are crossreactive between viral strains, can beshown to recognize
the same region of NP sequence as the subgroup-specific CTL by using target
cells transfected with appropriately truncated NP genes (10) . We have now
screened such cultures on target cells treated with peptides derived from the NP
sequence .
Table II shows the results from a polyclonal culture initiated and maintained
as described (14) . Most of the NP-specificCTL activity is directed at the000H-
terminal region ofNP defined by transfectant IMP1295 (which expresses amino
acids 1, 2, 328-498) . When tested on peptide-treated target cells, a detectable
proportion of the NP-specific activity was found to be directed at peptide 365-
379 derived from either the 1934 (28) or 1968 (26) NP sequence . To ensure
Sequence Specificity Restriction
element Reference
365-380 (IASNENMETMESSTLE) 1934-1943 H-2136 13
365-379 (IASNENMDAMESSTL) 1946-1968 H-21)6 13
365-379 (IASNENMDAMESSTL) All A strains H-2136 This paper
50-63 (SDYEGRLIQNSLTI) All Astrains H-2K ° This paper
335-349 (SAAFEDLRVLSFIRG) All Astrains HLA-1137 13BASTIN ET AL.
TABLE II
Polyclonal C57BL/10 CTL Activity Showing Crossreactive Specificity
for Peptide 365-379
Target cell Specific lysis*
* Obtained in standard "Cr-release assay using a killer-to-target ratio (K/
T) of 2.5 :1 as described in MaterialsandMethods.C57BL/10 mice were
primed with E61-13-H17 virus (1968 NP) and maintained in vitro by
repeated stimulation with X31 virus(1934 NP) as described (14) .
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that this crossreactive specificity existed at the clonal level the polyclonal culture
was cloned by limiting dilution and the resulting CTL clones were tested on
peptide-pulsed and transfected target cells . Each of the four clones isolated that
recognized NP from both 1934 and 1968 viruses were found to recognize
peptide 365-379 derived from either sequence .
The results for clone 11 are shown in Fig . 2. a-d show the specificity of clone
11 on target cells transfected with fragments of the 1968 NP gene . e andfshow
the recognition of peptide-pulsed target cells. Target cells not transfected with
the gene coding for the class I molecule Db were not recognized (data not
shown) .
Comparison of the Fine Specificities of Clones I1 and F5.
￿
In previous work we
defined clone F5 as specific for the 1968 NP sequence 365-380 (Table I) . It did
not recognize the 1934 sequence, which differs by an Asp to Glu substitution at
position 372 and an Ala to Thr at position 373. F5 was tested on a set of
truncated versions of the peptide with the 1968 sequence, each shorter than the
other by one amino acid (13) . The results gave a set of dose-response curves that
showed that 366-379 was recognized -10-fold more efficiently than 365-379,
and 368-379 -100-fold less efficiently than 365-379 .
The same analysis has now been done with clone 11, which crossreacts with
both the 1934 and 1968 sequences . The results are shown in Fig. 3 . The most
clear-cut difference in the set of dose-response curves is that, unlike clone F5,
clone 11 recognizes 365-379 and 366-379 with equal efficiency .
To extend the analysis with clones 11 and F5, a set ofamino acid substitutions
was introduced into the 365-379 peptide of the 1968 sequence as summarized
in Table III. To identify which amino acid was responsible for the ability of
clone F5 to differentiate between the 1934 and 1968 sequences, the two inde-
pendent substitutions Asp to Glu (372) and Ala to Thr (373) were introduced .
Finally, the effect of a conservative substitution in the pair of hydrophobic
Infected
AX31 (1934 NP)-infected LDb cells 69.0
LDb uninfected 0.5
Peptide pulsed
1934 ; 365-380 peptide-pulsed LDb 40.0
1968 ; 365-379 peptide-pulsed LD b 56.5
1968 ; 335-349 peptide-pulsed LDb 9.5
Transfected
PVU 1295 (1-327) 2.5
IMP 1295 (1, 2, and 328-498) 52.51514
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RecognitionbyC57BL/10
clone 1 I ofthe same set oftarget cells
as described in Fig . 1 . (0) Clone 11
tested on transfected or peptide-
pulsed target cells ; (O) clone 1 I tested
on untreated L/Db Cells .
FIGURE 3 .
￿
Recognition by clone 11 ofLD b target cells
in the presence ofdecreasing concentrationsof truncated
peptides all from the 1968 NP sequence . (0) 365-379 ;
(O) 366-379 ; (") 367-379; (") 368-379 ; and (") 369-
379 . Clone I 1 was used at a K/T ratio of 2 :1 .
residues in the middle of the peptide was assessed by introducing Ile for Met at
position 374 .
The set of resulting dose-response curves for clones 11 and F5 are shown in
Figs . 4 and 5, respectively . Comparison of Figs . 3 and 4 shows that the dose-
response curve forclone 11 on thereference peptide 365-379 (1968) has shifted .
In Fig . 3 the plateau level of lysis was higher (70-80%) and was reached at ~1
a b c
NP 1-498 PVU 705 BAN 577/793
1-130 1-87,160-498
d e f
imp 1295 PEPTIDE
1,2,328-498 50-63
PEPTIDE
365-38011934)
-vTABLE III
Summary ofthe Effects on Recognition by Clones 11 and F5 ofAmino Substitutions and
Deletions in Peptide 365-379 (1986 Sequence)
Peptide
￿
Wild-type 1,986 sequence
365-380 ; 1934 sequence
￿
- - - - - - - ET- - - - - -
￿
-1
￿
NR*
365-379 (D-Eat372)
￿
-------E------
￿
^- 1 /e
￿
NR
365-379 (A-Tat373)
￿
--------T-----
￿
^-1/e
￿
^-40
365-379 (M-I at 374)
￿
- - - - - - - - - I - - - -
￿
^-'/IS ￿-50
366-379 ; 1968 sequence
￿
- - - - - - - - - - - - -
￿
^-1
￿
^-10
The effects are referred to in terms of the relative potency in the cytotoxicity assay of the
substituted peptides compared with wild-type sequence as described in the text .
* NR, Not recognized .
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Relative potency of
peptidecompared
with wild-type
365-379(1986
sequence)
Clone I 1
￿
CloneF5
FIGURE 4. Recognition by clone 11 of LD° target cells in the presence of decreasing
concentrations of peptides containing amino acid substitutions. (0) 365-379 (wild-type 1968) ;
(/) 366-379 (wild-type 1968) ; (*) 365-380 (wild type 1934) ; (EI) 365-379 (1968) with Asp
to Glu substitution at position 372; (A) 365-379(1968) with Ala to Thr substitution at position
373 ; (*) 365-379 (1968) with Met to Ile substitution at position 374 . Clone 11 was used at a
K/T ratio of 2.5 :1 .
nM/liter of peptide, whereas in Fig . 4 the plateau was lower (40-50% lysis) and
was reached at ^-10 nM/liter of peptide . This reduction in lytic activity of clone
11 correlated with recent (3 wk) thawing from frozen stock. Although the
absolute levels of lysis by clone 11 varied in this way, the pattern of recognition
on the various peptides remained constant (data not shown) . In each experiment
the reference peptide 365-379 (1968) was therefore included as an internal
standard against which the relative potency of peptides with amino acid substi-
tutions could be measured .
Fig . 4 shows that 365-379, 366-379 of the 1968 sequence and 365-380 of
1934 sequence were recognized with approximately equal efficiency by clone1516
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FIGURE 5 . Recognition by clone F5 of LD b target cells in the presence of decreasing
concentrations of peptides containing amino acid substitutions. (0) 365-379 (wild-type 1968) ;
(/) 366-379 (wild-type 1968); (p) 368-379 (wild-type 1968) ; (A) 365-379 with the Ala to
Thr substitution at position 372 ; (") 365-379 with the Met to Ile substitution at position 374 .
Both the 365-380 (wild-type 1934) and 365-379 with theAsp to Glu substitution at position
372 failed to be recognized by F5 (data not shown) . Clone F5 was used at a K/T ratio of 2:1 .
10510`' 5x103 'i03 500 250 125 52 .5 31 .25 15 .6 7,E 3 .9 1 .95 0 .9E 0 .49
11 . The two peptides with single substitutions at positions 372 and 373 were
recognized approximately eightfold less efficiently than the reference peptide
365-379. Thus, the two natural sequences containing either Asp(372), Ala(373)
or Glu(372), Thr(373) were recognized more efficientlyby clone 11 than peptides
containing either one of the two alternative sequences . The peptide containing
the substitution Met to Ile at position 374 was recognized ^-16-fold less efficiently
than the reference peptide .
Clone F5 gave a different set of dose-response curves with the same set of
peptides, shown in Fig . 5. As mentioned above, both clones were restricted
through the class I molecule Db . Neither the peptide 365-380 (1934 sequence)
nor the peptide with the single substitution Asp to Glu at position 372 were
recognized by clone F5 at any concentration tested (data not shown) . This
demonstrated that Asp at residue 372 controlled the specificity defined by clone
F5 . Of interest, and in contrast to clone 11, the single substitution Ala to Thr at
position 373 was recognized ^-40-fold more efficiently than the wild-type se-
quence . In addition, the Met to Ile substitution at position 374 also resulted in
an ^-50-fold increase in potency for clone F5 . These differential effects on the
recognition by the two clones are summarized in Table 111 .
Comparison of the Recognition by CTL of Purified Recombinant NP and Peptide
366-379 in the Cytotoxicity Assay . The NP from A/NT/60/68 influenza virus
has been produced as a recombinant protein in E. coli (19) . The NP gene from
the same virus has been used throughout in the transfection experiments thata
BASTIN ET AL.
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￿
Recognition by (a) clone F5 and (b) clone 1 I of LDb target cells in the presence
of decreasing concentrations of peptides and recombinant NP . (/) 366-379 (wild-type 1968) ;
(A) 365-379 (1968) with the Asp to Glu substitution at position 372 ; (") recombinant NP .
The clones were used at a K/T ratio of 3:1 .
defined the specificities of clones 11 and F5 (5, 10). In view of the fact that NP
has been detected at the surface of influenza virus-infected cells (29, 30), but
not on cells transfected with the NP gene (10), it was of interest to compare
purified whole NP with appropriate peptides for its ability to sensitize target cells
for lysis in the 5'Cr-releaseassay. Purified NPwastitrated in the assay as described
in Materials and Methods . The preparation used wasjudged to be predominantly
correctly folded, as it reacted correctly with a panel of mAbs and bound viral
RNA in vitro to form characteristic aggregates observed by electron microscopy
(19) .
Fig . 6 shows that at high concentration (0 .5 jM) whole NP was recognized
inefficiently by clones 11 and F5 . Higher concentrations could not be accurately
used as the protein has a low solubility . Over the same molar concentration range
the peptide 366-379 was found to be ^-200-fold more efficient at inducing lysis
of target cells by both CTL clones, i.e, an -200-fold higher concentration of
whole NP was necessary to induce the same level of target cell lysis . The peptide
with the Asp to Glu substitution at position 372 was included in the experiment
to highlight the differences in specificity between the two clones .
For some proteins, denaturation without degradation can be sufficient to allow
recognition by class II-restrictedT cells (31, 32) . Recombinant NP was treated
with 7 M guanidine HCl and was reduced and alkylated before testing in the
cytotoxicity assay with clones 11 and F5 . This treatment did not enhance the
ability of the material to sensitize target cells. In two experiments the activity of
the preparations was slightly reduced (data not shown) .1518
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Discussion
The characteristic feature oftheCTL response to influenza is the predominant
specificity for conserved epitopes of the nonglycoproteins of the virus (1, 2, 5-
9) . This contrasts with the neutralizing antibody response that is predominantly
directed at strain-specific epitopes on the viral glycoproteins (33) . Evidence has
accumulated that influenza-specific CTL are able to recognize proteins of the
virus that do not have a known means of transport to the cell surface (5-9) . In
both mice and humans the viral nucleoprotein is an antigen recognized by CTL
that crossreact between differentA virus strains (5-7) .
Table II and Figs . 1 and 2 show that the conserved epitopes on NP recognized
by CBA and C57BL CTL can be defined with short peptides . These results
complete our earlier analysis (10) with target cells transfected with deletion
mutants of theNP gene . All four epitopes mapped in the deletion analysis have
now been defined with synthetic peptides . A fifth epitope has been demonstrated
(12, 13) with an additional peptide in the human CTL response . These results
are summarized in Table I . A sixth peptide epitope recognized by BALB/c CTL
(Kd-restricted) has recently been defined using the same techniques (Askonas, B.
A ., personal communication) .
The finding that CTL can recognize short synthetic peptides in vitro raises
the possibility of using peptide vaccines to prime or restimulate CTL in vivo .
However, the strict genetic control of responsiveness to individual epitopes by
the polymorphic class I MHC genes (11, 12) may limit the usefulness of this
approach in the genetically diverse human population .
The data in Figs . 3-6 and summarized in Table III define the specificity
differences between clones 11 and F5, both of which recognize the wild-type
sequence 365-379 (1968 isolate) and both of which are restricted through the
class I molecule Db . Certain points are worth considering . The major amino acid
determining the specificity of clone F5 is the Asp to Glu substitution at position
372 . The 1968 sequence with this change alone results in an approximately
eightfold reduction in efficiency of recognition by clone 11, and abolishes
recognition by clone F5 . This demonstrates that clone F5 is sensitive to a
conservative amino acid change, the addition ofa single methylene group to the
peptide being sufficient to completely prevent recognition .
Although reduced in potency, the peptide with Glu at position 372 was still
recognized by clone 11 . If a single site of interaction with Db exists for this
peptide, the Asp to Glu change could not be acting by preventing association
with the Db molecule, and the result obtained would imply that Asp at position
372 interacts with the F5 T cell receptor . The alternative possibility is that the
peptide 365-379 interacts with two different sites on Db, recognized mutually
exclusively by clones 11 and F5 . In this case the Asp to Glu substitution could
be thought of as preventing association of the peptide at one site on Db but not
at the other . Competition experiments with the various peptides for binding to
the isolated Db molecule may shed light on this point .
Another feature of interest is that certain amino acid substitutions in the
peptide can have opposite effects on recognition by the two T cell clones (shown
in Fig . 5 and summarized in Table III) . For instance, the substitution of lie for
Met at position 374 resulted in an ^-50-fold enhancement in potency of theBASTIN ET AL .
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peptide for clone F5 and an -I 6-fold reduction in potency for clone 11, when
compared with the wild-type sequence . The molecular interpretations of this
result again depend on whether more than one site of interaction with the Db
molecule exists . If there is a single site, then any substitution interfering with the
association of peptide with Db would be expected to reduce the efficiency of
recognition by all Db-restrictedCTL specific for that peptide, regardless oftheir
fine specificities . The observed effects would then be interpreted by Ala (373)
and Met (374) interacting slightly differently with the clone 11 and F5 T cell
receptors, but not playing a role in the association with Db . An additional
example of two class I-restricted epitopes on one 16-amino-acid peptide has
recently been described in the Kd-restricted murine CTL response to the human
HLA CW3 molecule (34), and is a common finding with class 1I-restricted T
cells (35-39) .
These results with recognition of peptides by class I-restricted T cells are
closely related to those with class II-restricted T cells (reviewed in references
40-42) and are open to parallel interpretations . The correct interpretation of
the results will depend on the structural analysis of the molecules involved and
their interactions . The techniques described here can now be applied to the viral
antigens recognized in association with the HLA molecules for which crystal
structure is being elucidated .
Much recent discussion has concentrated on the question of whether degra-
dation of protein antigens is an obligatory requirement for recognition by all T
cells (42, 43) . Examples exist of class 11-restricted T cell clones that appear to
recognize complete folded protein antigens (42), clones that recognize proteins
that are denatured but not degraded, and finally, those that recognize short
peptides but not complete proteins whether denatured or not (31, 32).
Influenza NP can be detected with antibody at the surface of influenza virus-
infected cells (10, 29, 30) . This is surprising because its sequence contains neither
a hydrophobic signal peptide, nor a characteristic membrane anchor sequence .
In view of its presence on the infected cell surface the question arises whether
the epitopes we have defined in vitro with short peptides could be recognized in
vivo as part of the complete protein .
Fig . 6 shows a comparison of recognition by clones 11 and F5 of the complete
recombinant NP with the peptide 366-379. The dose-response curves show that
the peptide is recognized ^-200-fold more efficiently than the whole protein by
these T cell clones in this type of assay . These results are consistent with the
work of Wraith and Vessey (44) who found that the Db-restricted CTL clone
A3.1 (which is specific for the same region of sequence as clone F5, but in the
1934 NP) (13), could proliferate in response to high concentrations of the 1934
NP (0 .45-1 .8 ttM/liter) presented by a fixed or ammonium chloride treated
macrophage preparation .
The low level of recognition of whole NP compared with peptide in the 6-h
cytotoxicity assay suggests that the epitopes around the sequence 366-379 are
poorly exposed on the complete recombinant molecule in solution . The dena-
turing conditions tested had no detectable effect on revealing these epitopes to
clones 1 1 or F5 . These results extend the work on transfected target cells (5, 10)1520
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and are consistent with the suggestion that degradation of NP occurs in the
virus-infected cell before recognition by CTL.
The L cells used as targets might be expected to be capable of endocytosing
soluble NP and degrading it within membrane-bound vesicles (45), as is thought
to occur during presentation with class II molecules (46) . However, if this
mechanism is at work it appears to be inefficient for the epitope studied here
under these conditions . This result is related to the findings of Morrison et al .
(47), who have shown that class I-restricted CTL specific for hemagglutinin
were not able to recognize A20-1.11 B lymphoma cells exposed to the soluble
protein in conditions where presentation to class II-restricted T cells occurred
efficiently . Taken with the finding that HA-specific CTL can recognize target
cells that express the HA molecule as an obligatory cytoplasmic protein (48),
these results imply that the mechanisms by which protein antigens are made
visible to class I- and class I1-restricted T cells may be different .
Summary
The conserved epitopes of influenza nucleoprotein (NP) recognized by class I
MHC-restricted CTL from CBA (H-2k) and C57BL/10 (H-2b) mice have been
defined in vitro with synthetic peptides 50-63 and 365-379, respectively . Two
D'-restricted clones were described that recognize different epitopes on peptide
365-379 . Finally, the recognition of complete NP was shown to be ^-200-fold
less efficient than peptide in the cytotoxicity assay. These phenomena are closely
related to results with class II-restricted T cells and they strengthen the hypoth-
esis that influenza proteins are degraded in the infected cell before recognition
by class I-restricted CTL.
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